Guard Therapeutics announced that the company has appointed Dr. Michael Reusch as Chief Medical Officer. Dr. Reusch has over 30 years' experience in global clinical development and regulatory processes from leading positions in the pharmaceutical industry, most recently in the role of Senior Medical Director at Astellas Pharma. He will take up his new position on 1 January 2022. Dr. Michael Reusch is a physician and pharmacist who has previously worked at the global pharmaceutical companies Servier, Fujisawa and Astellas Pharma.